This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Dec;102(12):1908-9.

doi: 10.1111/j.1360-0443.2007.02047.x.

Why we do what we do-delivery of buprenorphine and the treatment of opioid addiction

Affiliations

Affiliation

¹ Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. lwalter@ucla.edu

PMID: 18031426
DOI: 10.1111/j.1360-0443.2007.02047.x

Comment

Why we do what we do-delivery of buprenorphine and the treatment of opioid addiction

Walter Ling. Addiction. 2007 Dec.

. 2007 Dec;102(12):1908-9.

doi: 10.1111/j.1360-0443.2007.02047.x.

Author

Affiliation

¹ Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. lwalter@ucla.edu

PMID: 18031426
DOI: 10.1111/j.1360-0443.2007.02047.x

No abstract available

PubMed Disclaimer

Comment on

A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
Bell J, Shanahan M, Mutch C, Rea F, Ryan A, Batey R, Dunlop A, Winstock A. Bell J, et al. Addiction. 2007 Dec;102(12):1899-907. doi: 10.1111/j.1360-0443.2007.01979.x. Epub 2007 Sep 3. Addiction. 2007. PMID: 17784896 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information